|
Implant Sciences Explosives Trace Detection Equipment to Be Deployed at the Summit of the Americas
WILMINGTON, MA, Apr 10, 2012 (MARKETWIRE via COMTEX) --
Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a
high technology supplier of systems and sensors for homeland security
and defense markets, today announced that the Colombian National
Police has selected Implant Sciences explosives trace detection
equipment as part of the security plan for the Summit of the
Americas. Both the Quantum Sniffer(TM) QS-H150 handheld explosives
trace detectors and the Quantum Sniffer(TM) QS-B220 benchtop
narcotics and explosives trace detectors will be used at the Sixth
Summit of the Americas, where 34 heads of state and government of the
Americas will convene in Cartagena, Colombia on April 14 and 15,
2012.
Implant Sciences systems will be deployed at entry checkpoints as the
primary explosives screening mechanism for people, bags, and
briefcases in a layered security environment.
The Summit of the Americas are institutionalized gatherings of the
heads of state and government of the Western Hemisphere where leaders
discuss common policy issues, affirm shared values and commit to
concerted actions at the national and regional level to address
continuing and new challenges faced in the Americas.
"I appreciate the effort that Implant Sciences and their local
representatives have put into making it possible for us to use the
QS-H150 and QS-B220 during the Summit of the Americas," commented
Mayor General Jose Roberto Leon Riano, Subdirector General of the
Colombian National Police. "It is very encouraging to see such
cooperation in ensuring a safe and peaceful event, and I look forward
to working with them in the future."
Implant Sciences President and CEO Glenn D. Bolduc added, "Our
equipment has been selected to provide trace detection for the most
important political summit of our hemisphere because of its proven
performance in a wide range of applications. We are working closely
with the Colombian National Police on delivery, set up and
implementation of our handheld and benchtop units. This is an
opportunity for us to not only provide security at this critical
event, but also to receive additional exposure for our products in
front of key governmental decision makers from South, Central, and
North America."
About the Quantum Sniffer(TM) QS-H150
The QS-H150 is a handheld
explosives trace detector that uses Ion Mobility Spectrometry (IMS)
to rapidly detect and identify trace amounts of a wide variety of
military, commercial, and homemade explosives. The QS-H150 uses no
radioactive materials and features a low-maintenance design that is
self-calibrating and self-clearing, providing very high levels of
operational availability.
About the Quantum Sniffer(TM) QS-B220
The QS-B220, introduced in
May 2011, is a benchtop explosives and narcotics trace detector that
uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify
trace amounts of a wide variety of military, commercial, and homemade
explosives, plus narcotic substances. The QS-B220 continues the
Implant Sciences tradition of freedom from radioactive materials, low
total cost of ownership, and high operational availability.
About Implant Sciences
Implant Sciences develops, manufactures and
sells sophisticated sensors and systems for Security, Safety, and
Defense (SS&D) markets. The Company has developed proprietary
technologies used in its commercial explosive and narcotics trace
detection systems which ship to a growing number of locations
domestically and internationally. Implant Sciences' QS-H150 portable
explosives trace detector has received Qualified Anti-Terrorism
Technology Designation and the Company's QS-B220 benchtop explosives
and narcotics trace detector has received a Developmental Testing &
Evaluation (DT&E) Designation by the U.S. Department of Homeland
Security under the Support Anti-terrorism by Fostering Effective
Technology Act of 2002 (the SAFETY Act). For further details on the
Company and its products, please visit the Company's website at
www.implantsciences.com.
Safe Harbor Statement
This press release may contain certain
"forward-looking statements," as that term is defined in the Private
Securities Litigation Reform Act of 1995. Such statements are based
on management's current expectations and are subject to risks and
uncertainties that could cause the Company's actual results to differ
materially from the forward-looking statements. Such risks and
uncertainties include, but are not limited to, the risks that our
explosives detection products and technologies (including any new
products we may develop) may not be accepted by the Transportation
Security Administration or by other U.S. or foreign government and
law enforcement agencies or commercial consumers of security
products; economic, political and other risks associated with
international sales and operations could adversely affect our sales;
our business is subject to intense competition and rapid
technological change; the risks that our markets are subject to
technological change and that our success depends on our ability to
develop and introduce new products; that our success depends on our
ability to obtain new patents and operate without infringing on the
proprietary rights of others; that we may not obtain the patents we
have applied for; that the validity and breadth of claims in
technology patents involve complex legal and factual questions and,
therefore, may be highly uncertain; that any patents we may obtain
may be may be challenged and subsequently invalidated, that we may
incur substantial costs in asserting our patent rights; and other
risks and uncertainties described in our filings with the Securities
and Exchange Commission, including its most recent Forms 10-K, 10-Q
and 8-K. Such statements are based on management's current
expectations and assumptions which could differ materially from the
forward-looking statements.
Contact:
Implant Sciences Corporation
Company Contact:
Glenn Bolduc
CEO
978-752-1700
Email Contact
Investor Contact:
Laurel Moody
646-810-0608
Email Contact
SOURCE: Implant Sciences Corporation
http://www2.marketwire.com/mw/emailprcntct?id=2B8F4FBC90A1317D
http://www2.marketwire.com/mw/emailprcntct?id=9CCDEFF142A33AEA
[ Back To TMCnet.com's Homepage ]
|
Call Center/CRM
Info Tech 
IP Communications 
Mobile 
Green 
Satellite 
Robotics 
Internet Telephony Magazine
Click here to read latest issue
CUSTOMER 
Cloud Computing Magazine
Click here to read latest issue
M2M Evolution Magazine
